Table 2.
Chr | Start | End | Candidate gene | Comparisons | Gene function | References |
---|---|---|---|---|---|---|
1 | 74,271,042 | 74,292,681 | NR2E1 | TT vs XP/LW vs XP | Behavioral defense response | 12 |
1 | 112,907,047 | 112,942,219 | CCNB2 | TT vs XP/DU vs XP/LW vs XP | Litter size trait | 13 |
1 | 137,387,925 | 137,690,666 | IGF1R | TT vs XP/LW vs XP | Growth Traits | 14 |
1 | 157,820,645 | 157,836,904 | SERPINB8 | TT vs XP/LW vs XP | Environmental adaptation | 15 |
1 | 157,841,510 | 157,866,913 | SERPINB10 | TT vs XP/LW vs XP | Implicated in UV-induced stress | 16 |
1 | 157,872,212 | 157,886,753 | SERPINB2 | TT vs XP/LW vs XP | Immune response | 17 |
1 | 227,811,204 | 227,963,110 | TRPM6 | DU vs XP/MS vs XP | Litter size trait | 18 |
2 | 64,844,792 | 64,890,939 | ADGRE5 | LW vs XP/MS vs XP | An activation marker on T cells | 19 |
2 | 79,627,603 | 79,631,270 | PROP1 | TT vs XP/MS vs XP/LW vs XP | Growth traits | 20 |
4 | 46,730,461 | 46,767,427 | DECR1 | TT vs XP//MS vs XP/LW vs XP |
Carcass and meat quality, lipid composition |
21 |
4 | 69,616,035 | 69,806,496 | CYP7B1 | MS vs XP/DU vs XP/LW vs XP | Male reproductive behavior | 22 |
4 | 82,663,581 | 82,697,813 | TBX19 | DU vs XP/LW vs XP | Development and growth | 23 |
5 | 22,406,364 | 22,421,990 | STAT6 | MS vs XP/DU vs XP/LW vs XP | Immune response | 24 |
5 | 22,549,008 | 22,556,194 | STAC3 | DU vs XP/LW vs XP | Vertebrate skeletal muscle development | 25 |
6 | 85,095,409 | 85,185,799 | EYA3 | LW vs XP/MS vs XP | Male and female seasonal estrus | 26,27 |
6 | 93,665,138 | 93,685,197 | RSPO1 | TT vs XP/MS vs XP | Sex development | 28 |
6 | 95,900,086 | 95,994,044 | RLF | TT vs XP/MS vs XP/LW vs XP | Muscle development and growth | 29 |
8 | 573,421 | 601,944 | UVSSA | TT vs XP/DU vs XP/LW vs XP | Environmental adaptation | 30 |
8 | 101,640,944 | 101,645,609 | IL2 | TT vs XP/MS vs XP/DU vs XP | T-cell growth factor | 31 |
9 | 36,885,212 | 37,006,396 | EXPH5 | TT vs XP/DU vs XP/LW vs XP |
Adaptation to Arctic or Antarctic environments |
32 |
13 | 140,693,382 | 140,728,980 | CD80 | DU vs XP/LW vs XP | T cell activation | 33 |
14 | 46,400,026 | 46,408,366 | RHBDD3 | DU vs XP/LW vs XP | Suppress the production of IL-6 | 34 |
14 | 46,408,053 | 46,442,086 | EWSR1 | DU vs XP/LW vs XP | Intramuscular fat | 35 |
14 | 47,902,860 | 47,905,440 | SELENOM | DU vs XP/LW vs XP | Growth trait | 36 |
14 | 47,946,396 | 48,040,822 | LIMK2 | DU vs XP/LW vs XP | Male infertility | 37 |
14 | 48,040,881 | 48,051,660 | PIK3IP1 | DU vs XP/LW vs XP | Inhibition of T-cell activation | 38 |
15 | 39,037,893 | 39,133,041 | VEGFC | TT vs XP/MS vs XP | High-altitude adaptation | 6 |
15 | 47,388,300 | 47,520,236 | ADAM32 | TT vs XP/MS vs XP | Male reproduction | 39 |
15 | 94,620,269 | 94,628,546 | MSTN | DU vs XP/LW vs XP |
Inhibit of skeletal muscle development and growth |
40 |
15 | 115,809,180 | 116,760,790 | SPAG16 | TT vs XP/DU vs XP | Male reproductive function | 41 |